FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36947511000001109: Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
32301000001112 Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
32321000001117 Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) Is a Product containing precisely olanzapine 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) Has specific active ingredient Olanzapine true Inferred relationship Existential restriction modifier
Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) 28 tablet Has AMP True Olanzapine 10mg tablets (Alissa Healthcare Research Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start